Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Growth(%) 96.50-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 96.50 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202496.50
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2024 96.5
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹98.6 Cr -1.1% -10.2% -35.7% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,295.6 Cr -4.3% -17.9% 21.8% Stock Analytics
KIRI INDUSTRIES ₹3,375.4 Cr -0.8% 0.6% 48.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,683.4 Cr -7.5% -9.4% -26.8% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,377.3 Cr 2.8% -5.7% 63.9% Stock Analytics
BODAL CHEMICALS ₹780.0 Cr -0.2% -4.7% -21.1% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-1.1%

-10.2%

-35.7%

SENSEX

0.7%

4.7%

6.1%


You may also like the below Video Courses